期刊
CHEMISTRY & BIOLOGY
卷 15, 期 11, 页码 1207-1219出版社
CELL PRESS
DOI: 10.1016/j.chembiol.2008.10.011
关键词
-
资金
- National Institutes of Health, National Institute on Drug Abuse [DA03934, DA000489, DA9158, DA3801]
The extensive physiological influence of transmission through the CB2 cannabinoid receptor makes this G protein-coupled receptor (GPCR) a promising therapeutic target for treating neuropathic pain, inflammation, and immune disorders. However, there is little direct structural information pertaining to either GPCR or CB2-receptor ligand recognition and activation. The present work helps characterize experimentally the ligand-binding interactions of the human CB2 (hCB2) receptor. This study illustrates how our overall experimental approach, ligand-assisted protein structure (LAPS), affords direct determination of the requirements for ligand binding to the hCB2 receptor and discrimination among the binding motifs for ligands that activate therapeutically relevant GPCRs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据